Table 2 Five-year results for death, myocardial infarction, and stroke by AKI status in the full cohort
Events | Number at period start | One-year risk | Five-year risk | Hazard ratio | ||
|---|---|---|---|---|---|---|
Crude | Adjusteda | |||||
Endpoint | n | n | % (95% CI) | % (95% CI) | (95% CI) | (95% CI) |
Death | ||||||
Non-AKI | 90 | 743 | 2.3 (1.4 to 3.7) | 12.1 (10.0 to 14.7) | 1 (reference) | 1 (reference) |
AKI | 76 | 287 | 9.4 (6.6 to 13.4) | 26.5 (21.2 to 32.0) | 2.4 (1.8 to 3.3) | 1.6 (1.1 to 2.2) |
Stage 1 | 59 | 238 | 8.8 (5.8 to 13.2) | 24.8 (19.8 to 30.8) | 2.3 (1.6 to 3.1) | 1.4 (1.0 to 2.1) |
Stage 2 + 3 | 17 | 49 | 12.2 (5.7 to 25.2) | 34.7 (23.2 to 49.7) | 3.4 (2.0 to 5.7) | 2.3 (1.4 to 3.9) |
Myocardial infarction | ||||||
Non-AKI | 23 | 708 | 1.4 (0.7 to 2.5) | 3.3 (2.1 to 4.8) | 1 (reference) | 1 (reference) |
AKI | 14 | 278 | 1.8 (0.7 to 3.9) | 5.0 (2.9 to 8.1) | 1.7 (0.9 to 3.3) | 1.5 (0.7 to 3.2) |
Stage 1 | 11 | 230 | 1.7 (0.6 to 4.1) | 4.7 (2.6 to 7.6) | 1.6 (0.8 to 3.3) | 1.4 (0.7 to 3.1) |
Stage 2 + 3 | 3 | 48 | 2.1 (0.2 to 9.6) | 6.3 (1.6 to 15.4) | 2.2 (0.7 to 7.4) | 2.0 (0.6 to 6.9) |
Stroke | ||||||
Non-AKI | 31 | 736 | 1.6 (0.9 to 2.8) | 4.2 (2.9 to 5.8) | 1 (reference) | 1 (reference) |
AKI | 14 | 282 | 2.1 (0.9 to 4.4) | 5.0 (2.8 to 7.9) | 1.3 (0.7 to 2.4) | 0.9 (0.5 to 1.8) |
Stage 1 | 10 | 236 | 1.8 (0.7 to 3.9) | 5.0 (2.8 to 7.9) | 1.1 (0.5 to 2.2) | 0.8 (0.4 to 1.6) |
Stage 2 + 3 | 4 | 46 | 2.1 (0.9 to 4.4) | 3.2 (1.6 to 5.7) | 2.5 (0.9 to 7.0) | 1.8 (0.6 to 5.3) |